Inventor
Steven D. Rosen
Inventor
San Francisco, CA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides16%
C12NMicroorganisms or enzymes10%
A01KAnimal husbandry9%
C12YEnzymes5%
C07HSugars4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
8,216,580'Sulfatases and methods of use thereof'20127,070,971'Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6'20066,967,093'Glycosyl sulfotransferase-3'20056,933,142'HEC-G1CNAC6ST'20056,852,518'Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6'20056,844,175'Methods of inhibition using glycosyl sulfotransferase-3'20056,395,882'Selectin ligands'20026,380,371'Endoglycan: a novel protein having selectin ligand and chemokine presentation activity'20026,365,365'Method of determining whether an agent modulates glycosyl sulfotransferase-3'20026,265,192'Glycosly sulfortransferase-3'20015,977,080'Sulfated disaccharide inhibitors of selectins, methods for synthesis and therapeutic use'19995,972,625'Assays for inhibitors of leukocyte adhesion'19995,925,349'Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor'19995,840,844'Soluble lymphocyte homing receptors'19985,783,693'Methods for synthesizing sulfated disaccharide inhibitors of selectins'19985,695,752'Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor'19975,652,343'Method for purification of L-selectin ligands'19975,580,862'Sulfate ligands for L-selectins and methods of preventing sulfate addition'19965,489,578'Sulfated ligands for l-selectin and methods of treating inflammation'19965,484,891'Selectin ligands'19965,318,890'Assays for inhibitors of leukocyte adhesion'19945,304,640'DNA sequence encoding a selectin ligand'19945,227,369'Compositions and methods for inhibiting leukocyte adhesion to CNS myelin'19935,216,131'Lymphocyte homing receptors'19935,098,833'DNA sequence encoding a functional domain of a lymphocyte homing receptor'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2012Patents assigned to UNIV CALIFORNIA (21)· patent assignee history
1992–1998Patents assigned to GENENTECH INC (6)· patent assignee history
1992–2012Based in San Francisco, CA, US· patent location history
2001–2005Patents assigned to SYNTEX INC (2)· patent assignee history
2005Patents assigned to SYNTEX LLC (2)· patent assignee history
2012Patents assigned to NAWROTH ROMAN (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV CALIFORNIA | 21 | 1992–2012 |
| GENENTECH INC | 6 | 1992–1998 |
| SYNTEX INC | 2 | 2001–2005 |
| SYNTEX LLC | 2 | 2005 |
| NAWROTH ROMAN | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 25 | 1992–2012 |